Open World Leadership Center

openworld.gov

Since its founding by Congress in 1999, the Open World Leadership Center has enabled more than 27,000 current and future Eurasian leaders to experience American democracy, civil society and community life; work with their American counterparts; stay in American homes; and gain new ideas and inspiration for implementing change back home. Some 6,000 American host families and their communities in all 50 states have partnered with the U.S. Congress and Open World to make this ambitious public diplomacy effort possible.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Government Business

UNQORK AWARDED A SOFTWARE LICENSING PROGRAM CONTRACT BY THE STATE OF CALIFORNIA

Unqork | January 12, 2022

news image

Unqork, the leading enterprise no-code platform, today announced that Unqork is now an approved vendor for the Software Licensing Program (SLP) within the State of California. The contract simplifies the procurement process for state and local agencies in California, allowing them to leverage Unqork's no-code platform to build mission-critical, enterprise-grade software in a codeless architecture. Administered by California's Department of General Services, the SLP program...

Read More

LEIDOS ACQUIRES US SECURITY SOLUTIONS COMPANY DYNETICS FOR $1.65BN

army-technology | February 03, 2020

news image

Leidos has completed its previously announced acquisition of US-based applied research and national security solutions company Dynetics in a deal valued at approximately $1.65bn in cash. Initially announced in December last year, the acquisition was funded by Leidos using excess cash on hand and $1.25bn of short-term borrowing capacity. Dynetics has now become a wholly owned subsidiary of Leidos, and its CEO David King will continue to lead the business, reporting directly to Leidos chairman and...

Read More

U.S. GOVERNMENT SIGNS $450 MILLION COVID-19 VACCINE CONTRACT WITH JOHNSON & JOHNSON

JOHNSON & JOHNSON | March 31, 2020

news image

The Trump administration has made another move in the race to combat and stop the viral outbreak of COVID-19, also known as the coronavirus, around the globe. The Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) recently signed a deal for a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen. The order has been specified as a “new vaccine asset for 2019 Novel Coronavirus (COVID-19).” It is the largest amoun...

Read More

HERE’S WHY TRUMP AND ELON MUSK SEE POTENTIAL IN A DRUG CALLED CHLOROQUINE TO TREAT CORONAVIRUS

CNBC | March 19, 2020

news image

When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine. Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the ...

Read More
news image

Government Business

UNQORK AWARDED A SOFTWARE LICENSING PROGRAM CONTRACT BY THE STATE OF CALIFORNIA

Unqork | January 12, 2022

Unqork, the leading enterprise no-code platform, today announced that Unqork is now an approved vendor for the Software Licensing Program (SLP) within the State of California. The contract simplifies the procurement process for state and local agencies in California, allowing them to leverage Unqork's no-code platform to build mission-critical, enterprise-grade software in a codeless architecture. Administered by California's Department of General Services, the SLP program...

Read More
news image

LEIDOS ACQUIRES US SECURITY SOLUTIONS COMPANY DYNETICS FOR $1.65BN

army-technology | February 03, 2020

Leidos has completed its previously announced acquisition of US-based applied research and national security solutions company Dynetics in a deal valued at approximately $1.65bn in cash. Initially announced in December last year, the acquisition was funded by Leidos using excess cash on hand and $1.25bn of short-term borrowing capacity. Dynetics has now become a wholly owned subsidiary of Leidos, and its CEO David King will continue to lead the business, reporting directly to Leidos chairman and...

Read More
news image

U.S. GOVERNMENT SIGNS $450 MILLION COVID-19 VACCINE CONTRACT WITH JOHNSON & JOHNSON

JOHNSON & JOHNSON | March 31, 2020

The Trump administration has made another move in the race to combat and stop the viral outbreak of COVID-19, also known as the coronavirus, around the globe. The Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) recently signed a deal for a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen. The order has been specified as a “new vaccine asset for 2019 Novel Coronavirus (COVID-19).” It is the largest amoun...

Read More
news image

HERE’S WHY TRUMP AND ELON MUSK SEE POTENTIAL IN A DRUG CALLED CHLOROQUINE TO TREAT CORONAVIRUS

CNBC | March 19, 2020

When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine. Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us